XANAX Drug Patent Profile
✉ Email this page to a colleague
When do Xanax patents expire, and what generic alternatives are available?
Xanax is a drug marketed by Upjohn and is included in two NDAs.
The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xanax
A generic version of XANAX was approved as alprazolam by NOVITIUM PHARMA on October 19th, 1993.
Summary for XANAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Patent Applications: | 4,048 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for XANAX |
Drug Sales Revenues: | Drug sales revenues for XANAX |
What excipients (inactive ingredients) are in XANAX? | XANAX excipients list |
DailyMed Link: | XANAX at DailyMed |
Pharmacology for XANAX
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for XANAX
US Patents and Regulatory Information for XANAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-004 | Nov 27, 1985 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XANAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-003 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-003 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XANAX
See the table below for patents covering XANAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 2012190 | ⤷ Try a Trial | |
Switzerland | 549041 | VERFAHREN ZUR HERSTELLUNG VON 6-(O-HALOGENPHENYL)-1-METHYL-4H-S-TRIAZOLO (4,3-A) (1,4-BENZODIAZEPINEN. (Hypnotic pharmaceutical compsns - contg 1-methyl-6 (ortho-chlorophenyl)-5-triazolo (4,3-a) (1,4) benzodiazepine) | ⤷ Try a Trial |
Israel | 33859 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |